New Zealand markets close in 4 hours 52 minutes

Spruce Biosciences, Inc. (SPRB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.5400-0.0300 (-1.17%)
At close: 04:00PM EST
2.5000 -0.04 (-1.57%)
After hours: 05:18PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 59.13M
Enterprise value -26.59M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.49
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.65

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-88.53%
S&P500 52-week change 314.56%
52-week high 328.4900
52-week low 32.2500
50-day moving average 33.3197
200-day moving average 38.2193

Share statistics

Avg vol (3-month) 33.98M
Avg vol (10-day) 3757.9k
Shares outstanding 523.46M
Implied shares outstanding 6N/A
Float 84.08M
% held by insiders 10.03%
% held by institutions 1100.41%
Shares short (30 Dec 2021) 41.21M
Short ratio (30 Dec 2021) 40.12
Short % of float (30 Dec 2021) 46.83%
Short % of shares outstanding (30 Dec 2021) 45.18%
Shares short (prior month 29 Nov 2021) 4527.74k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sep 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-24.15%
Return on equity (ttm)-45.12%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -41.21M
Net income avi to common (ttm)-41.45M
Diluted EPS (ttm)-1.8090
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)92.32M
Total cash per share (mrq)3.93
Total debt (mrq)6.61M
Total debt/equity (mrq)5.52
Current ratio (mrq)10.37
Book value per share (mrq)5.12

Cash flow statement

Operating cash flow (ttm)-35.34M
Levered free cash flow (ttm)-21.94M